JP Morgan Chase’s Nautilus Biotechnolgy NAUT Stock Holding History
Bought
Maintained
Sold
Other funds holding NAUT
PA
ACM
CM
CFM
CA
JP Morgan Chase's NAUT Position: Q2 2026 in Review
JP Morgan Chase opened a new position in Nautilus Biotechnolgy (NAUT) in Q2 2026: 614,177 shares worth $1.1M. The stake represents ﹤0.01% of the portfolio and ranks #4599 among its holdings. This is a return to the name: JP Morgan Chase previously reported a position in NAUT as recently as Q3 2025.
JP Morgan Chase first reported a position in NAUT in Q4 2021 and has held it in 17 quarters since. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.
- JP Morgan Chase held 614,177 shares of Nautilus Biotechnolgy worth $1.1M as of Q2 2026.
- Nautilus Biotechnolgy was a new JP Morgan Chase position in Q2 2026.
- Nautilus Biotechnolgy made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #4599 holding.
- JP Morgan Chase first reported a position in Nautilus Biotechnolgy in Q4 2021 and has held it in 17 quarters since.
- 93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.
Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.